TTIPF
THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP. (TTIPF)
$42
About THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP. (TTIPF)
Thiogenesis Therapeutics Corp. engages in the development of novel drug formulations that act as precursors for rare diseases. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.58
52 Week Low
$0.00
Market cap
29.4M
Dividend yield
0.00%
Volume
--
Avg. volume
2,105
P/E ratio
-4.16
THIOGENESIS THERAPEUTICS by THIOGENESIS THERAPEUTICS CORP. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.58
52 Week Low
$0.00
Market cap
29.4M
Dividend yield
0.00%
Volume
--
Avg. volume
2,105
P/E ratio
-4.16